Orthofix

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Orthofix sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).

14 total trials none currently recruiting 5 completed top decile by trial count

Orthofix: 14 sponsored US clinical trials, none currently recruiting.

Orthofix sponsors 14 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. The most-studied condition in this pipeline is Cervical Disc Degenerative Disorder, with 1 trials.

Top-decile sponsor footprint

Orthofix ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

14 total, page 1 of 1

ACTIVE NOT RECRUITING

A Data Collection Protocol to Evaluate the Real World Usage of the Orthofix AccelStim Device to Treat Fresh Metatarsal Fractures

NCT07286357
ACTIVE NOT RECRUITING

Orthofix PhysioStim PEMF Ankle Fusion Retrospective

NCT07282067
ACTIVE NOT RECRUITING

Post Market Evaluation of Clinical Safety and Performance of the Fitbone Transport and Lengthening System

NCT06400732
ACTIVE NOT RECRUITING

A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices

NCT05082090
ACTIVE NOT RECRUITING NA

M6-C Artificial Cervical Disc Two-Level IDE Pivotal Study

NCT04982835
TERMINATED NA

Comparative Analysis of Virtuos and Autograft in Lumbar Fusion

NCT05614284
TERMINATED NA

PEMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears

NCT03339492
COMPLETED

Study Using the CervicalStim Device Following Cervical Fusion

NCT03177473
COMPLETED

Study Using the SpinalStim Device Following Lumbar Fusion Surgery

NCT03176303
TERMINATED NA

Efficacy and Safety of an Active Pulsed Electromagnetic Field for the Treatment of Osteoarthritis of the Knee

NCT02436590
COMPLETED

Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion

NCT00988338
COMPLETED

Trinity Evolution in Posterior or Transforaminal Lumbar Interbody Fusion (PLIF/TLIF)

NCT00965380
COMPLETED

Trinity Evolution in Anterior Cervical Disectomy and Fusion (ACDF)

NCT00951938
TERMINATED NA

Advent™ Cervical Disc Versus ACDF for Treatment of One Level Degenerative Disc Disease (IDE Study)

NCT00637312

Therapeutic Areas

Cervical Disc Degenerative Disorder 1
Spinal Disorders/Injuries 1
Tibiotalar Arthrodesis 1
Ankle Arthrodesis 1
Metatarsal Fracture 1
Limb Asymmetry 1
Limb Defect 1
Limb Deformity 1
Fracture Nonunion 1
Fractures, Closed 1

How the Orthofix archive is shaped

14 indexed studies, none listed as recruiting (0% open); 5 completed (36%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Cervical Disc Degenerative Disorder (1 trial), 9 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Orthofix: archived-pipeline peers nationwide

Peers matched on 14 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Orthofix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Orthofix3-C Institute for Social DevelopmentAbbott Medical OpticsAbbott RDx CardiometabolicAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA10xBio22nd Century Group23andMe3 Waves Wellness
Orthofix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Orthofix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 14 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Orthofix page

14 registered trials is a research-attention snapshot, not an endorsement of Orthofix or any single study.

  • None of Orthofix's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Cervical Disc Degenerative Disorder is the condition Orthofix studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cervical Disc Degenerative Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Orthofix pipeline card: 14 registered trials from official public datasets.Report a data error.